immunity(redirected from Governmental Tort Immunity)
Also found in: Dictionary, Thesaurus, Legal, Encyclopedia.
The mechanisms of immunity are essentially concerned with the body's ability to recognize and dispose of substances which it interprets as foreign and harmful to its well-being. When such a substance enters the body, complex chemical and mechanical activities are set into motion to defend and protect the body's cells and tissues. The foreign substance, usually a protein, is called an antigen, that is, one that generates the production of an antagonist. The most common response to the antigen is the production of antibody. The antigen--antibody reaction is an essential component of the overall immune response. A second type of activity, cellular response, is also an essential component.
The various and complex mechanisms of immunity are basic to the body's ability to protect itself against specific infectious agents and parasites, to accept or reject cells and tissues from other individuals, as in blood transfusions and organ transplants, and to protect against cancer, as when the immune system recognizes malignant cells as not-self and destroys them.
There has been extensive research into the body's ability to differentiate between cells, organisms, and other substances that are self (not alien to the body), and those that are nonself and therefore must be eliminated. A major motivating force behind these research efforts has been the need for more information about growth and proliferation of malignant cells, the inability of certain individuals to develop normal immunological responses (as in immunodeficiency conditions), and mechanisms of failure of the body to recognize its own tissues (as in autoimmune diseases).
The two kinds of lymphocytes that are important to establishment of immunity are T lymphocytes (T cells) and B lymphocytes (B cells). (See under lymphocyte.) The T lymphocytes differentiate in the thymus and are therefore called thymus-dependent. There are several types involved in cell-mediated immunity, delayed hypersensitivity, production of lymphokines, and the regulation of the immune response of other T and B cells.
The B lymphocytes are so named because they were first identified during research studies involving the immunologic activity of the bursa of Fabricius, a lymphoid organ in the chicken. (Humans have no analogous organ.) They mature into plasma cells that are primarily responsible for forming antibodies, thereby providing humoral immunity.
Most of the B lymphocytes activated by the presence of their specific antigen become plasma cells, which then synthesize and export antibodies. The activated B lymphocytes that do not become plasma cells continue to reside as “memory” cells in the lymphoid tissue, where they stand ready for future encounters with antigens that may enter the body. It is these memory cells that provide continued immunity after initial exposure to the antigens.
There are two types of humoral immune response: primary and secondary. The primary response begins immediately after the initial contact with an antigen; the resulting antibody appears 48 to 72 hours later. The antibodies produced during this primary response are predominantly of the IgM class of immunoglobulins.
A secondary response occurs within 24 to 48 hours. This reaction produces large quantities of immunoglobulins that are predominantly of the IgG class. The secondary response persists much longer than the primary response and is the result of repeated contact with the antigens. This phenomenon is the basic principle underlying consecutive immunizations.
The ability of the antibody to bind with or “stick to” antigen renders it capable of destroying the antigen in a number of ways; for example, agglutination and opsonization. Antibody also “fixes” or activates complement, which is the second component of the humoral immune system. Complement is the name given a complex series of enzymatic proteins which are present but inactive in normal serum. When complement fixation takes place, the antigen, antibody, and complement become bound together. The cell membrane of the antigen (which usually is a bacterial cell) then ruptures, resulting in dissolution of the antigen cell and a leakage of its substance into the body fluids. This destructive process is called lysis.
The T lymphocyte becomes sensitized by its first contact with a specific antigen. Subsequent exposure to the antigen stimulates a host of chemical and mechanical activities, all designed to either destroy or inactivate the offending antigen. Some of the sensitized T lymphocytes combine with the antigen to deactivate it, while others set about to destroy the invading organism by direct invasion or the release of chemical factors. These chemical factors, through their influence on macrophages and unsensitized lymphocytes, enhance the effectiveness of the immune response.
Among the more active chemical factors are lymphokines, which are potent and biologically active proteins; their names are often descriptive of their functions: Ones that directly affect the macrophages are the macrophage chemotactic factor, which attracts macrophages to the invasion site; migration inhibitory factor, which causes macrophages to remain at the invasion site; and macrophage-activating factor, which stimulates the metabolic activities of these large cells and thereby improves their ability to ingest the foreign invaders.
Another factor, a protein called interferon, is produced by the body cells, especially T lymphocytes, following viral infection or in response to a wide variety of inducers, such as certain nonviral infectious agents and synthetic polymers.
A portion of the population of T lymphocytes is transformed into killer cells by the lymphocyte-transforming factor (blastogenic factor). These activated lymphocytes produce a lymphotoxin or cytotoxin that damages the cell membranes of the antigens, causing them to rupture.
In order to ensure an ample supply of T lymphocytes, two factors are at work: lymphocyte-transforming factor stimulates lymphocytes that have already undergone conversion to sensitized T lymphocytes, so that they increase their numbers by repeated cell division and clone formation; in the absence of antigens, transfer factor takes over the task of sensitizing those lymphocytes that have not been exposed to antigen.
It is apparent that the immune response brings about intensive activity at the site of invasion; it is not only the pathogen that is destroyed, but invariably, there is death or damage to some normal tissues.
For a discussion of abnormalities of the immune response system, see immune response.
In order for an individual to acquire immunity one's body must be stimulated to produce its own immune response components (active immunity) or these substances must be produced by other persons or animals and then passed on to the person (passive immunity). Active immunity can be established in two ways: by having the disease or by receiving modified pathogens and toxins. When an individual is exposed to a disease and the pathogenic organisms enter the body, the production of antibody is initiated. After recovery from the illness, memory cells remain in the body and stand ready as a defense against future invasion. It is possible, through the use of vaccines, bacterins, and modified toxins (toxoids), to stimulate the production of specific antibodies without having an attack of the disease. These are artificial means by which an individual can acquire active immunity.
Sometimes it is desirable to provide “ready-made” immune bodies, as in cases in which the patient has already been exposed to the antigen, is experiencing the symptoms of the disease, and needs reinforcements to help mitigate its harmful effects. Examples of conditions for which an individual may be given such passive immunity include tetanus, diphtheria, and a venomous snake bite. The patient is given immune serum, which contains gamma globulin, antibodies (including antitoxin) produced by the animal from which the serum was taken.
It is not always necessary that the patient actually suffer from the disease and exhibit its symptoms before passive immunity is provided. In some instances in which exposure to an infectious agent is suspected, immune bodies may be given to ward off a full-blown attack or at least to lessen its severity.
Another way in which immunity can be passively acquired is across the placental barrier from fetus to mother. The maternal antibody thus acquired serves as protection for the newborn until he can actively establish immunity on his own. Although humoral immunity can be acquired in this way, cellular immunity cannot.
immunity/im·mu·ni·ty/ (ĭ-mu´nĭ-te) the condition of being immune; the protection against infectious disease conferred either by the immune response generated by immunization or previous infection or by other nonimmunologic factors.
immunity(im-u'nit-e) [L. immunitas, exemption]
B-cell–mediated immunityHumoral immunity.
cell-mediated immunityAbbreviation: CMI.
Unlike B cells, T cells cannot recognize foreign antigens on their own. Foreign antigens are recognized by antigen-presenting cells (APCs) such as macrophages, which engulf them and display part of the antigens on the APC's surface next to a histocompatibility or “self-” antigen (macrophage processing). The presence of these two markers, plus the cytokine interleukin-1 (IL-1) secreted by the APCs activates CD4 helper T cells (TH cells), which regulate the activities of other cells involved in the immune response.
CMI includes direct lysis of target cells by cytotoxic T cells, creation of memory cells that trigger a rapid response when a foreign antigen is encountered for the second time, and delayed hypersensitivity to tissue and organ transplants. T cells also stimulate the activity of macrophages, B cells, and natural killer cells. These functions are controlled largely by the secretion of lymphokines such as the interleukins, interferons, and colony-stimulating factors. Lymphokines facilitate communication and proliferation of the cells in the immune system.
community immunityHerd immunity.
Members of every region or community should be alerted to local or widespread communicable diseases for which vaccination is available. Offering public immunization sessions through local health departments, schools, colleges and places of business, as well as public and private health care agencies will increase the percentage of persons who are vaccinated and will decrease risk of communicable disease epidemics.
Antibodies produced by plasma B cells, found mainly in the blood, spleen, and lymph nodes, neutralize or destroy antigens in several ways. They kill organisms by activating the complement system; neutralize viruses and toxins released by bacteria; coat the antigen (opsonization) or form an antigen-antibody complex to stimulate phagocytosis; promote antigen clumping (agglutination); and prevent the antigen from adhering to host cells.
T-cell–mediated immunityCell-mediated immunity.
immunityThe relative ability to resist infection or the effects of any toxic or dangerous substance. Immunity may be inherent or acquired as a result of prior infection or immunization. Active immunity involves the production of ANTIBODIES. Passive immunity is that conferred by antibodies derived from another person or animal and injected or received across the placenta or in the breast milk. Passive immunity is much less persistent than active immunity.
immunityresistance to foreign ANTIGENS such as a virus. Immunity can be either active, in which the body produces its own IMMUNE RESPONSE after exposure to a pathogen or a vaccine, or passive in which ready-made antibodies are supplied in a serum (or obtained naturally from the mother).
immunitythe protected condition provided by the immune system or by medical interventions. natural (innate) immunity includes (1) protective barriers - skin and mucous membranes, and their antibacterial secretions; (2) humoral defences - substances in the body fluids, produced or activated when micro-organisms invade, and promoting the function of (3) phagocytic cells - white blood cells and macrophages. acquired immunity (1) active: the result of specific defence mechanisms, each initiated by exposure to a particular antigen and effective against subsequent exposures; includes deliberate immunization by injection of a harmless dose of organisms (alive or dead) or their toxins; (2) passive: for urgent treatment (e.g. of tetanus infection or snake bite) transfer of serum or cells from an already immune individual See also lymphatic system.
2. the condition of an organism whereby it successfully resists or is not susceptible to injury or infection. See also memory.
2. the resistance to poisons or medications developed over a usually long period of gradually increasing exposure.
Patient discussion about immunity
Q. What can I do to build muscle and develop immunity? I'm Mickey, 21. My height is 5’5” and I weigh 176 lbs. I love out door games especially soccer. I have poor immunity that I get sick very often. What can I do to build muscle and develop immunity?